Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

NuVasive infringed five patents from a spine surgeon, a jury determined, according to an April 22 report from Bloomberg Law. The jury ruled that screw assemblies from the Reline, Armada and VuePoint ...

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the ...

Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release. The acquisition expands Globus Medical’s reach in the musculoskeletal ...

Globus Medical is gearing up for a series of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.

In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...

SI-BONE, Inc. reported $48 million in sales and an operating loss of $4.5 million for the quarter ending December 31, 2024. The full year 2024 revenue, which was in line with Wall Street’s ...

Globus Medical (NYSE:GMED ... which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems ...

These innovations underscore Globus Medical’s commitment to advancing anterior spine surgery by offering comprehensive solutions tailored to address both patient anatomy and surgeon preference.